Antimicrobial Prescribing in the United States: Good News, Bad News

Annals of Internal Medicine

Volumn 138, Issue 7, 2003, Pages 605-606

  Besser, Richard E ^a,b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; ERYTHROMYCIN; MACROLIDE; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; HUMAN; INFECTION; PENICILLIN ALLERGY; PHARYNGITIS; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; STREPTOCOCCUS PYOGENES; UNITED STATES; CLINICAL PRACTICE; DRUG UTILIZATION; NOTE; RESPIRATORY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; DRUG RESISTANCE, MICROBIAL; DRUG UTILIZATION; HUMANS; PHYSICIAN'S PRACTICE PATTERNS; PRESCRIPTIONS, DRUG; RESPIRATORY TRACT INFECTIONS; UNITED STATES;

EID: 0037389363     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-138-7-200304010-00020     Document Type: Review

References (20)

1. Institute of Medicine. Emerging Infections: Microbial Threats to the Health of the United States. Washington, DC: National Academy Pr; 1994.
2. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917-24. [PMID: 11136262]
3. Lipsitch M, Samore MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis. 2002;8:347-54. [PMID: 11971765]
4. McCaig LF, Hughes JM. Trends in antimicrobial drug prescribing among office-based physicians in the United States. JAMA. 1995;273:214-9. [PMID: 7807660]
5. Emmer C, Besser R. Combating antimicrobial resistance: intervention programs to promote appropriate antibiotic use. Infections in Medicine. 2002;19: 160-73.
6. Dowell SF. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics. 1998;101:S163-84.
7. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR, et al. Principles of appropriate antibiotic use for treatment of acute respiratory tract infections in adults: background, specific aims, and methods. Ann Intern Med. 2001;134:479-86. [PMID: 11255524]
8. Dowell SF, Butler JC, Giebink GS, Jacobs MR, Jernigan D, Musher DM, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance - a report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Pediatr Infect Dis J. 1999;18:1-9. [PMID: 9951971]
9. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America. Clin Infect Dis. 2000;31:347-82. [PMID: 10987697]
10. McCaig LF, Besser RE, Hughes JM. Trends in antimicrobial prescribing rates for children and adolescents. JAMA. 2002;287:3096-102. [PMID: 12069672]
11. Steinman MA, Gonzales R, Linder JA, Landefeld CS. Changing use of antibiotics in community-based outpatient practice, 1991-1999. Ann Intern Med. 2003;138:525-33.
12. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Infectious Diseases Society of America. Clin Infect Dis. 2002;35:113-25. [PMID: 12087516]
13. Schwartz B, Marcy SM, Phillips WR, Gerber MA, Dowell SF, Pharyngitis-principles of judicious use of antimicrobial agents. Pediatrics. 1998;101:171-4.
14. Cooper RJ, Hoffman JR, Bartlett JG, Besser RE, Gonzales R, Hickner JM, et al. Principles of appropriate antibiotic use for acute pharyngitis in adults: background, Ann Intern Med. 2001;134:509-17. [PMID: 11255530]
15. Martin JM, Green M, Barbadora KA, Wald ER. Erythromycin-resistant group A streptococci in schoolchildren in Pittsburgh. N Engl J Med. 2002;346: 1200-6. [PMID: 11961148]
16. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-54. [PMID: 11401897]
17. Hyde TB, Gay K, Stephens DS, Vugia DJ, Pass M, Johnson S, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 2001;286:1857-62. [PMID: 11597287]
18. Ho PL, Yung RW, Tsang DN, Que TL, Ho M, Seto WH, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother. 2001;48:659-65. [PMID: 11679555]
19. Levin BR. Minimizing potential resistance: a population dynamics view. Clin Infect Dis. 2001;33 Suppl 3:S161-9. [PMID: 11524714]
20. Petersen M. Less return in marketing of medicines, a study says. The New York Times. 2002;12 December:C5.